A
Alto Neuroscience Inc
NYSE:ANRO
Alto Neuroscience Inc
NYSE:ANRO
Price:
27.72
USD
6.37%
Market Closed
Market Cap:
$885.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Alto Neuroscience Inc
NYSE:ANRO
|
US |
|
S
|
Shanghai Jiaoda Onlly Co Ltd
SSE:600530
|
CN |
|
HELLA GmbH & Co KGaA
XETRA:HLE
|
DE |
|
S
|
Socionext Inc
TSE:6526
|
JP |
|
O
|
Okada Aiyon Corp
TSE:6294
|
JP |
|
Z
|
Zijin Mining Group Co Ltd
OTC:ZIJMF
|
CN |
|
N
|
NCR Atleos Corp
NYSE:NATL
|
US |
|
Shanghai Lily & Beauty Cosmetics Co Ltd
SSE:605136
|
CN |
|
Taita Chemical Co Ltd
TWSE:1309
|
TW |
|
D
|
Dinglong Culture Co Ltd
SZSE:002502
|
CN |
|
G
|
Good Fellow Healthcare Holdings Ltd
HKEX:8143
|
HK |
|
H
|
Hannong Chemicals Inc
KRX:011500
|
KR |
|
Beyond Inc
NYSE:BYON
|
US |
|
P
|
PetroVietnam Power Engineering Consulting JSC
VN:PPE
|
VN |
|
A
|
Asian Granito India Ltd
NSE:ASIANTILES
|
IN |
|
T
|
Terranet AB
STO:TERRNT B
|
SE |
|
C
|
Celsion Corp
LSE:0HUZ
|
US |
|
Travel Food Services Ltd
NSE:TRAVELFOOD
|
IN |
|
Demant A/S
OTC:WILYY
|
DK |
Income Statement
Earnings Waterfall
Alto Neuroscience Inc
Alto Neuroscience Inc
Income Statement
Alto Neuroscience Inc
Alto Neuroscience Inc
Currency:
| Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Interest Expense |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(38)
|
(52)
|
(71)
|
(63)
|
(69)
|
(70)
|
(70)
|
(66)
|
(66)
|
|
| Selling, General & Administrative |
(8)
|
(12)
|
(17)
|
(18)
|
(22)
|
(23)
|
(23)
|
(22)
|
(21)
|
|
| Research & Development |
(30)
|
(40)
|
(53)
|
(46)
|
(47)
|
(47)
|
(47)
|
(44)
|
(46)
|
|
| Operating Income |
(38)
N/A
|
(52)
-38%
|
(71)
-35%
|
(63)
+10%
|
(69)
-8%
|
(70)
-2%
|
(70)
0%
|
(66)
+6%
|
(66)
0%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
1
|
2
|
5
|
6
|
7
|
7
|
6
|
5
|
4
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Total Other Income |
1
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(36)
N/A
|
(50)
-37%
|
(66)
-32%
|
(57)
+13%
|
(61)
-7%
|
(63)
-3%
|
(65)
-3%
|
(62)
+4%
|
(63)
-2%
|
|
| Net Income | ||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(36)
|
(50)
|
(66)
|
(57)
|
(61)
|
(63)
|
(65)
|
(62)
|
(63)
|
|
| Net Income (Common) |
(36)
N/A
|
(50)
-37%
|
(66)
-32%
|
(57)
+13%
|
(61)
-7%
|
(63)
-3%
|
(65)
-3%
|
(62)
+4%
|
(63)
-2%
|
|
| EPS (Diluted) |
-1.42
N/A
|
-2.82
-99%
|
-2.44
+13%
|
-2.13
+13%
|
-2.5
-17%
|
-2.35
+6%
|
-2.41
-3%
|
-2.31
+4%
|
-1.84
+20%
|
|
Switch to:
Switch to:
See Also
Discover More
